Blis Technologies Limited Update of the Company Performance

10 Birch Street
PO Box 5804
Dunedin 9058
New Zealand

Telephone: 03 474 1338
Fax: 03 474 9050
Email: info@blis.co.nz
Website: www.blis.co.nz


22 January 2018




Blis Technologies Limited Update of the Company Performance.

Third Quarter FY 2018, ending 31 December 2017.
Blis Technologies Limited announces the interim results (unaudited) for the 3
rd

quarter ending 31 December 2017. Revenue for the quarter was $1.6 m, with a
positive EBITDA of $0.2 m and a small net profit.
The 3
rd
quarter revenue was 6% up on the previous quarter and similar to the same
period last year.
Based on known and expected orders for the final quarter, we are forecasting
ongoing revenue recovery with double digit growth compared with the same period
last year, a positive EBITDA and a Net Profit for the quarter, however this will not be
sufficient to fully offset the EBITDA loss previously reported for the first half year (HY
18 EBITDA deficit of $953,000 reported on 27 October 2017).
Our revised full year guidance is for revenue in excess of $5 m and an EBITDA loss
that is expected to be less than $0.5 m.
Sales by the Company are subject to major fluctuations due to distributor buying
patterns which in any one quarter period can disguise the underlying in market
consumer sales growth being experienced for that period. We continue to see in
market year on year customer sales grow across our major markets in Europe and
the USA.
During the 3
rd
quarter the company has taken further measures to control its’ cost
base focusing resources on growth generating initiatives. In conjunction with this,
plans are progressing well for new finished product market opportunities for Australia,
Canada and Internet based sales along with a revised 2018 winter campaign for New
Zealand pharmacies with our new distribution partner Radiant Health.

For further information please contact Brian Watson, CEO: 027 7059133




Brian Watson
Chief Executive